In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right NowThe Motley Fool • 04/24/25
Dividend Kings Down Today: Why Johnson & Johnson (JNJ), Coca-Cola (KO) and Procter & Gamble (PG) Are Sliding24/7 Wall Street • 04/23/25
Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUAPRNewsWire • 04/21/25
2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. GovernmentThe Motley Fool • 04/20/25
One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs24/7 Wall Street • 04/18/25
The Relief Rally Is Over: 4 Incredible Dividend Monarchs Are Our Safest Ideas Now24/7 Wall Street • 04/17/25
4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent MarketThe Motley Fool • 04/17/25
This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a RowThe Motley Fool • 04/17/25
Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJZacks Investment Research • 04/16/25
Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare ConferenceBusiness Wire • 04/16/25
Healthy Returns: What drugmakers are saying about Trump's looming pharmaceutical tariffsCNBC • 04/16/25
J&J's Spravato momentum points to commercial viability of psychedelics for mental health, analysts sayProactive Investors • 04/15/25